(European Society of Cardiology) New research presented at ESC Congress today1 suggests that for acute coronary syndrome (ACS) patients who require percutaneous coronary intervention (PCI), treatment according to contemporary guidelines for dual anti-platelet therapy (DAPT) could be less preferable than sticking to older guidelines.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2xtrTGx
No comments:
Post a Comment